Yüklüyor......
Factors Predicting Late Recurrence for Estrogen Receptor–Positive Breast Cancer
BACKGROUND: Adjuvant endocrine therapy beyond 5 years reduces recurrence in patients with estrogen receptor–positive breast cancer. We have previously shown that immunohistochemical markers (IHC4) and two gene expression profile tests (recurrence score [RS] and PAM50 risk of recurrence [ROR]) are as...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3787911/ https://ncbi.nlm.nih.gov/pubmed/24029245 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djt244 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|